www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

US EUROPE AFRICA ASIA 中文
China / Society

Stem-cell trials give new hope to heart patients

By Shan Juan (China Daily) Updated: 2014-08-26 06:53

China's patients with chronic heart failure - a serious and common condition in which the heart cannot pump enough blood - will soon have access to the stem-cell-based therapy C-Cure.

Eight to 10 trial sites are expected to be set up at renowned public medical institutions in Beijing, Shanghai and Guangzhou, in addition to others around the world, to test the safety and effectiveness of the therapy.

"Participating in the trial will enhance the stem-cell research capacity of China, which remains uncompetitive worldwide," said Zhou Yujie, vice-president of Beijing Anzhen hospital.

It is the first stem-cell therapy for cardiology to enter Phase 3 of a clinical trial in China, he noted.

Chronic heart failure affects about 117 million people worldwide, including nearly 30 million in China, according to the World Health Organization and China's National Health and Family Planning Commission.

Current treatments mainly work to slow down progression of the disease, but with the exception of heart transplants they cannot cure the disease, said professor Gu Hong of Anzhen hospital.

"C-Cure is a revolutionary stem-cell treatment for heart failure. If it passes the Phase 3 clinical trial, it will enter the market to save the patients," she said.

The therapy reprograms the patient's own stem cells into new heart cells to rebuild the heart, according to Atta Behfar, director of cardiovascular regeneration at Mayo Clinic in the US.

He has played an active part in developing the technology that directs the patient's cells to become heart cells. Mayo Clinic was also involved in previous clinical trials of C-Cure in the United States.

"Stem-cell therapy aims to teach the human body to heal itself and we're moving gradually from promise to reality," he said.

Xu Guotong, head of the medicine department of Tongji Medical University in Shanghai, agreed but pointed out that China still lags far behind the US.

"The problem lies in a lack of government regulations and policies," he acknowledged.

Between a drug and a therapy, stem-cell treatment needs to be clearly defined by the health and drug authorities in China, he said.

shanjuan@chinadaily.com.cn

Highlights
Hot Topics
...
主站蜘蛛池模板: 日韩在线观看中文字幕 | 国产一区二区三区欧美 | 97视频在线观看免费视频 | 欧美毛片aaa激情 | 亚洲精品综合一区二区三区 | 中文字幕成人免费高清在线 | 成人精品第一区二区三区 | 欧美一级在线观看播放 | 在线日韩中文字幕 | 欧美一级大片在线观看 | 天天看夜夜操 | 香蕉一区二区三区观 | 精品视频免费在线 | 欧美日韩国产片 | 欧美特欧美特级一片 | 久草在线国产 | 91亚洲精品久久91综合 | 欧美日韩视频免费播放 | 免费看一级毛片欧美 | 九色porny真实丨国产18 | 亚洲精品免费视频 | 狠狠色噜噜狠狠狠米奇9999 | 成人高清视频在线观看 | 色视频一区二区三区 | 精品一区二区三区视频在线观看免 | 韩国美女豪爽一级毛片 | 国产三级在线视频播放线 | 在线观看免费国产成人软件 | 亚洲美女高清aⅴ视频免费 亚洲美女黄色片 | 久久精品国产半推半就 | 日本阿v视频在线观看高清 日本波多野结衣视频 | 色a在线| 国产美女一区二区 | 欧美激情精品久久久久 | 欧美一级毛片香蕉网 | 伊人2233| 久久狠狠色狠狠色综合 | 国产精选在线 | 国产一有一级毛片视频 | 狠狠色丁香久久婷婷综 | 亚洲七七久久精品中文国产 |